Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 22

Showing 22 citing articles:

A BODIPY-Naphtholimine-BF2 Dyad for Precision Photodynamic Therapy, Targeting, and Dual Imaging of Endoplasmic Reticulum and Lipid Droplets in Cancer
Nitish Chauhan, Mrunesh Koli, Rajib Ghosh, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 2838-2852
Open Access | Times Cited: 6
How to optimize the immune checkpoint blockade therapy for cancers?
Hui Guo, Yuchuan Hou, Chunxi Wang, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 343-348
Open Access | Times Cited: 4
Core–Satellite Nanoassembly Overcomes Spatial Heterogeneity of Dendric Cell Distribution in Pancreatic Tumors for Effective Chemoimmunotherapy
Gengjia Chen, Bo Li, Tan Li, et al.
ACS Nano (2025)
Closed Access
Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients
Lingyi Fu, Enliang Zhou, Shuo Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demir, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Association of tumor microbiome with survival in resected early-stage PDAC
Yixuan Meng, Chan Wang, Mykhaylo Usyk, et al.
mSystems (2025)
Open Access
Spatial distribution and activation changes of T cells in pancreatic tumors according to KRAS mutation subtype
Ji Hye Jeong, Dakyum Shin, Sang‐Yeob Kim, et al.
Cancer Letters (2025), pp. 217641-217641
Open Access
Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration
Vinicius Kannen, Ninni Elise Olafsen, Siddhartha Das, et al.
Biochemical Pharmacology (2025), pp. 116872-116872
Closed Access
Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First
Kim A. Reiss, Kevin C. Soares, Robert J. Torphy, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Nanomaterials in the diagnosis and treatment of gastrointestinal tumors: New clinical choices and treatment strategies
Liping Chen, Qingqing Li
Materials Today Bio (2025), pp. 101782-101782
Open Access
ESMO 2023 pancreatic cancer guidelines signal stepwise progress
Christoph Springfeld, Peter J. Bailey, Markus W. Büchler, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 2, pp. 362-365
Open Access | Times Cited: 3
Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS
Taku Aoki, Shozo Mori, Keiichi Kubota
Cancers (2024) Vol. 16, Iss. 5, pp. 910-910
Open Access | Times Cited: 2
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, Maria Grazia Doro, Laura Frogheri, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
ATX restricts anti-tumor eosinophil responses
Sharon Grisaru‐Tal, Ariel Munitz
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 221-223
Closed Access | Times Cited: 1
Spatial transcriptomics in pancreatic cancer: Advances, prospects and challenges
Yunlong Li, Yongxing Du, Rui Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104430-104430
Open Access | Times Cited: 1
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
(2024)
Open Access | Times Cited: 1
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases
Jingjie Yang, Fangshun Tan, Yaohui Chen, et al.
Journal of Physiology and Biochemistry (2024)
Closed Access | Times Cited: 1
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, MariaGrazia Doro, Laura Frogheri, et al.
Research Square (Research Square) (2024)
Open Access
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy
Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pancreatic cancer cells overexpressing interleukin 6 induce T-cell-mediated tumor clearance and durable anti-tumor immune response
Paige C. Arneson‐Wissink, Alexandra Bartlett, Heike Mendez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Targeting the CSF1/CSF1R signaling pathway: an innovative strategy for ultrasound combined with macrophage exhaustion in pancreatic cancer therapy
Qian Wang, Jian‐Hong Wang, Ke Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3421-3421
Open Access
Page 1

Scroll to top